Canadian General Medical Center Complex Company (TADAWUL:4021)
Saudi Arabia · Delayed Price · Currency is SAR 5.19
-0.10 (-1.89%)
At close: Sep 15, 2026
TADAWUL:4021 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 400 | 470 | 543 | 450 | 347 | 666 | |
Market Cap Growth | -21.26% | -13.33% | 20.72% | 29.78% | -47.98% | - |
Enterprise Value | 378 | 443 | 505 | 398 | 290 | 591 |
Last Close Price | 5.19 | 6.02 | 6.86 | 5.61 | 4.27 | 7.80 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 47.55 | 44.82 | 52.86 | 28.62 | 22.14 | 47.36 |
PS Ratio | 2.46 | 3.17 | 4.90 | 4.48 | 4.27 | 9.43 |
PB Ratio | 4.22 | 4.90 | 5.78 | 4.90 | 3.98 | 7.05 |
P/TBV Ratio | 4.22 | 4.90 | 5.78 | 4.90 | 3.98 | 7.05 |
P/FCF Ratio | 53.22 | 44.73 | - | 47.88 | 21.09 | - |
P/OCF Ratio | 33.07 | 23.67 | 131.32 | 35.23 | 20.96 | 418.78 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.33 | 2.99 | 4.56 | 3.97 | 3.58 | 8.37 |
EV/EBITDA Ratio | 15.07 | 20.50 | 37.60 | 24.16 | 15.27 | 32.10 |
EV/EBIT Ratio | 21.31 | 24.86 | 44.19 | 25.58 | 16.99 | 36.53 |
EV/FCF Ratio | 50.41 | 42.09 | - | 42.39 | 17.67 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.10 | 0.06 | 0.08 | 0.05 | 0.06 | 0.08 |
Debt / EBITDA Ratio | 0.37 | 0.25 | 0.47 | 0.25 | 0.26 | 0.40 |
Debt / FCF Ratio | 1.24 | 0.57 | - | 0.47 | 0.32 | - |
Net Debt / Equity Ratio | -0.22 | -0.29 | -0.34 | -0.53 | -0.59 | -0.62 |
Net Debt / EBITDA Ratio | -0.95 | -1.31 | -2.41 | -2.97 | -2.70 | -3.16 |
Net Debt / FCF Ratio | -2.81 | -2.69 | 8.32 | -5.21 | -3.13 | 1278.88 |
Asset Turnover | 1.22 | 1.17 | 0.96 | 0.91 | 0.72 | 0.62 |
Inventory Turnover | 28.38 | 33.41 | 21.80 | 15.82 | 17.35 | 42.88 |
Quick Ratio | 3.20 | 3.62 | 5.60 | 7.86 | 8.36 | 8.10 |
Current Ratio | 3.66 | 4.00 | 6.57 | 8.67 | 8.97 | 8.36 |
Return on Equity (ROE) | 9.09% | 11.05% | 11.06% | 17.57% | 17.25% | 15.07% |
Return on Assets (ROA) | 8.31% | 8.80% | 6.15% | 8.80% | 9.48% | 8.84% |
Return on Invested Capital (ROIC) | 20.30% | 23.07% | 17.45% | 34.89% | 41.41% | 46.88% |
Return on Capital Employed (ROCE) | 16.60% | 16.60% | 10.90% | 15.40% | 17.40% | 15.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.19% | 2.23% | 1.89% | 3.49% | 4.52% | 2.11% |
FCF Yield | 1.88% | 2.24% | -0.72% | 2.09% | 4.74% | -0.01% |
Dividend Yield | 2.88% | 2.16% | 0.73% | 3.39% | 4.68% | 3.85% |
Payout Ratio | 114.32% | 73.36% | 67.48% | 73.52% | 147.56% | 82.13% |
Buyback Yield / Dilution | -5.39% | - | - | - | - | -1900.35% |
Total Shareholder Return | -2.51% | 2.16% | 0.73% | 3.39% | 4.68% | -1896.51% |